Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,034 | -946 | 3,744 | -1,479 | -1,265 |
| Depreciation Amortization | 16 | 8 | 56 | 24 | 16 |
| Accounts receivable | 6,078 | 6,886 | -6,844 | 39 | 7 |
| Other Working Capital | 5,478 | 6,853 | -8,372 | -1,655 | -649 |
| Other Operating Activity | -5,195 | -6,456 | 8,315 | 1,010 | 727 |
| Operating Cash Flow | $5,344 | $6,344 | $-3,101 | $-2,062 | $-1,164 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 401 | 900 | 75 | -400 | -400 |
| PPE Investments | N/A | N/A | 8 | 8 | 7 |
| Purchase Sale Intangibles | N/A | N/A | -1,250 | -1,250 | N/A |
| Other Investing Activity | 0 | 0 | -1,250 | -1,250 | 0 |
| Investing Cash Flow | $401 | $900 | $-1,167 | $-1,642 | $-393 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 86 | 3 | 6,262 | 6,254 | 5,114 |
| Other Financing Activity | 0 | 0 | 1,431 | 1,117 | 1,117 |
| Financing Cash Flow | $86 | $3 | $7,694 | $7,371 | $6,230 |
| Beginning Cash Position | 3,494 | 3,494 | 69 | 69 | 69 |
| End Cash Position | 9,325 | 10,741 | 3,494 | 3,736 | 4,741 |
| Net Cash Flow | $5,830 | $7,247 | $3,426 | $3,667 | $4,673 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,344 | 6,344 | -3,101 | -2,062 | -1,164 |
| Free Cash Flow | 5,344 | 6,344 | -3,101 | -2,062 | -1,164 |